Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183,223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mucosal Healing Effectiveness and Safety of Anaprazole, a Novel PPI, vs. Rabeprazole in Patients With Duodenal Ulcers: A Randomized Double-Blinded Multicenter Phase II Clinical Trial.
Shu X, Zhu Z, Fu Y, Zhang Z, Wang J, Li X, He S, Fan H, Liu S, Zhang G, Tang J, Huang C, Du Q, Wang X, Xu B, Du Y, Chen Q, Wang B, Chen Y, Duan X, Xie Y, Huo L, Hou X, Lu N. Shu X, et al. Among authors: li x. Front Med (Lausanne). 2021 Jul 14;8:690995. doi: 10.3389/fmed.2021.690995. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34336894 Free PMC article.
Efficacy of keverprazan for duodenal ulcer: A phase II randomized, double-blind, parallel-controlled trial.
Tan ND, Liu XW, Liu CX, Li SB, Chen HH, Li X, Wu H, Liao AJ, Zhen YB, Shen PZ, Huo LJ, Liu HL, Shi RH, Zhang BQ, Zhang ZY, Wang JN, Zhan Q, Deng H, Shu X, Tuo BG, Wang QZ, Du SY, Qi LZ, Zhang GX, Peng Q, Wang BM, Ye B, Chen MH, Xiao YL. Tan ND, et al. Among authors: li sb, li x. J Gastroenterol Hepatol. 2022 Nov;37(11):2060-2066. doi: 10.1111/jgh.16000. Epub 2022 Sep 16. J Gastroenterol Hepatol. 2022. PMID: 36068945 Clinical Trial.
The efficacy and safety of keverprazan, a novel potassium-competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double-blind multicentre study.
Chen S, Liu D, Chen H, Liao A, Li F, Liu C, Li X, Li S, Zhang Y, Wang Y, Xia M, Guo Q, Miao X, Wen Z, Xu M, Yin H, Chen H, Chen M, Xiao Y. Chen S, et al. Among authors: li f, li s, li x. Aliment Pharmacol Ther. 2022 Jun;55(12):1524-1533. doi: 10.1111/apt.16959. Epub 2022 May 3. Aliment Pharmacol Ther. 2022. PMID: 35505467 Clinical Trial.
183,223 results
You have reached the last available page of results. Please see the User Guide for more information.